US$ 25.10
sarcoma bpc 157 Atezolizumab Shrinks Alveolar Soft Part Sarcomas BPC-157 Canada | Body Healing
Description
Based on pill count, the compliance with treatment was 99.3 1.5%, 97.8 3.8% and 97.1 6.7%, respectively

The reason to care about this on a blended product specifically: a co-formulated vial that reports only total peptide content instead of per-peptide purity is a methods-section liability

A 0.05% serum through microchannels behaves like 0.5% on intact skin
Uh, and also, you know, eating these-these compounds from plants these are phytochemicals
